Pathologic and gene expression comparison of CT- screen detected and routinely detected stage I/0 lung adenocarcinoma in NCCN risk-matched cohorts.-Reference-Cited by-同舟云学术

Pathologic and gene expression comparison of CT- screen detected and routinely detected stage I/0 lung adenocarcinoma in NCCN risk-matched cohorts.

Published:2021 Issue: Volume:29 Page:100486
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Burks Eric J.,Zhang Jiarui,Sullivan Travis B.,Shi Xingyi,Sands Jacob M.,Regis Shawn M.,McKee Brady J.,McKee Andrea B.,Zhang Sherry,Liu Hanqiao,Liu Gang,Spira Avrum,Beane Jennifer,Lenburg Marc E.,Rieger-Christ Kimberly M.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N. Engl. J. Med.,2011

2. Lung cancer screening;Wood;J. Natl. Compr. Cancer Netw. JNCCN,2012

3. Reduced lung-cancer mortality with volume CT screening in a randomized trial;de Koning;N. Engl. J. Med.,2020

4. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial;Pastorino;Ann. Oncol. Off J. Eur. Soc. Med. Oncol.,2019

5. EUPS-argues that lung cancer screening should be implemented in 18 months;Field;Br. J. Radiol.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial;Cancer Biomarkers;2024-05-22

2. Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma;Clinical Lung Cancer;2023-05

3. Vascular invasion identifies the most aggressive histologic subset of stage I lung adenocarcinoma: Implications for adjuvant therapy;Lung Cancer;2022-09